Acta Veterinaria et Zootechnica Sinica ›› 2024, Vol. 55 ›› Issue (11): 5124-5134.doi: 10.11843/j.issn.0366-6964.2024.11.028

• Animal Nutrition and Feeds • Previous Articles     Next Articles

Effects of Co-Treatment of Sodium Butyrate and Indole-3-Propionic Acid on Tight Junctions and Inflammatory Cytokines in Caco-2 Cells

Kexin WANG1(), Xian WU1, Haizhou GONG3, Qiaoyu FANG1, Xiangchen LI1, Yanan ZHANG1,2,*()   

  1. 1. Zhejiang Provincial Engineering Laboratory for Animal Health Inspection & Internet Technology, Key Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry of Zhejiang Province, College of Animal Science and Technology, College of Veterinary Medicine, Zhejiang A & F University, Hangzhou 311300, China
    2. The Key Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Science, Zhejiang University, Hangzhou 310058, China
    3. College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China
  • Received:2024-01-03 Online:2024-11-23 Published:2024-11-30
  • Contact: Yanan ZHANG E-mail:2661895207@qq.com;ynzhang1515@163.com

Abstract:

This study aims to investigate the effects of co-treatment of sodium butyrate and indole-3-propionic acid on the expression of tight junction-related proteins and inflammatory factors in Caco-2 cells. Caco-2 cells were administrated with 0.4 mmol·L-1 sodium butyrate and 0.1 mmol·L-1 indole-3-propionic acid each and together for 24 h; Then the transmembrane resistance (TEER) value, expression of tight junction related proteins, gene expression and secretion level of inflammatory cytokines were measured. The results showed that, compared with control group, the co-treatment of sodium butyrate and indole-3-propionic acid significantly increased the TEER value in Caco-2 cells (P < 0.01), while no significant changes were observed in sodium butyrate or indole-3-propionic group (P>0.05); In addition, the results by qPCR and Western blot showed that the relative expression of Claudin-2 mRNA was significantly down-regulated in the co-treatment group compared with the control group (P < 0.01); Compared with sodium butyrate group, the relative mRNA expression of Claudin-1 was significantly up-regulated in the co-treatment group (P < 0.05), and the protein expression of Claudin-1, ZO-1 and Occludin was highly significantly increased in the co-treatment group(P < 0.001); Compared with the indole-3-propionic acid group, the relative mRNA expression of ZO-1 was significantly up-regulated in the co-treatment group (P < 0.05), and the protein expression of Claudin-1 and ZO-1 was highly significantly increased (P < 0.001). For inflammatory cytokines, the relative mRNA expression levels of IL-6, IL-1β, IL-8 and TNF-α were significantly down-regulated in the co-treatment group (P < 0.05); Meanwhile, the results of ELISA showed that the co-treatment group highly significantly suppressed the secretion of IL-6, IL-1β, IL-8 and TNF-α in the cell supernatant compared with the control group (P < 0.001). In conclusion, compared with sodium butyrate or indole-3-propionic acid, the co-treatment of sodium butyrate and indole-3-propionic acid increased the TEER value, promoted the expression of tight junction proteins, suppressed the secretion of pro-inflammatory cytokines, and reduced intestinal permeability. Overall, these results suggested that the co-treatment of sodium butyrate and indole-3-propionic acid has a stronger role in enhancing intestinal epithelial cell barrier function and inhibiting inflammatory response.

Key words: sodium butyrate, indole-3-propionic acid, tight junction, inflammatory cytokines, Caco-2 cells

CLC Number: